Showing results (1-10 of 224) with videos related to
Sort By:
Pageof 23
Kidney International|October 1, 2020
Should we STOP immunosuppression for IgA nephropathy? Long-term outcomes from the STOP-IgAN trialChee Kay Cheung, Jonathan BarrattSeminars in Nephrology|March 8, 2025
The Rapidly Changing Treatment Landscape of IgA NephropathyChee Kay Cheung, Jonathan BarrattKidney International|August 1, 2015
Gluten and IgA nephropathy: you are what you eat?Chee Kay Cheung, Jonathan BarrattInternational Journal of Immunogenetics|November 25, 2021
Immunological drivers of IgA nephropathy: Exploring the mucosa-kidney linkHaresh Selvaskandan, Jonathan Barratt, Chee Kay CheungKidney International Reports|February 12, 2024
Novel Treatment Paradigms: Primary IgA NephropathyHaresh Selvaskandan, Jonathan Barratt, Chee Kay CheungPediatric Nephrology (Berlin, Germany)|June 19, 2017
New insights into the pathogenesis of IgA nephropathySee Cheng Yeo, Chee Kay Cheung, Jonathan BarrattNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2022
The role of complement in glomerulonephritis-are novel therapies ready for prime time?Chee Kay Cheung, John P Dormer, Jonathan BarrattClinical and Experimental Nephrology|February 14, 2019
New strategies and perspectives on managing IgA nephropathyHaresh Selvaskandan, Chee Kay Cheung, Masahiro Muto, et al.Expert Opinion on Investigational Drugs|January 2, 2023
IgA nephropathy: an overview of drug treatments in clinical trialsHaresh Selvaskandan, Guillermo Gonzalez-Martin, Jonathan Barratt, et al.Journal of Clinical Medicine|July 2, 2021
An Update on the Current State of Management and Clinical Trials for IgA NephropathyChee Kay Cheung, Arun Rajasekaran, Jonathan Barratt, et al.Pageof 23